An innovation platform that improves consumer health
Successful organizations will help consumers manage their health needs. Health providers, payers, pharmaceutical companies and employers can leverage PwC’s DoubleJump Health to help transform care and unburden the health system.
DoubleJump Health is PwC’s consumer health accelerator, dedicated to helping organizations deliver consumer-focused health and better economics at the same time.
Accelerating drug research and personalized medicine. Leveraging the power of health analytics to personalize health. Learn more
Leverage our consumer-centric experience platform aimed at engaging health consumers in a leading-edge health experience that integrates multiple health services, tasks and benefits.
By 2050, a third of Americans will have one or more chronic conditions such as metabolic disorder, diabetes or cardiovascular disease. DoubleJump Health is helping health organizations accelerate innovation to break the trajectory of chronic illness and better support individuals in getting well.
Donna is a 42-year-old mother of two who has recently been diagnosed with diabetes. In addition to her own diabetes, her husband is diabetic and her mother suffers from heart disease.
Donna is a persona, but she represents the health issues of millions of Americans. Every 23 seconds someone learns they have diabetes and one in four deaths is due to heart disease. DoubleJump Health innovations help mobilize health ecosystems and engage consumers so that a new and different future is possible.
Right now, there’s no way to get individualized answers about what a person requires to successfully manage chronic conditions, or get better results from health improvement efforts.
Often, the efficacy of fitness trackers drops off because there’s not enough value in the information collected; people briefly stick to doctors’ orders and then slide back into usual habits.
Bodylogical from DoubleJump Health presents an integrated picture of many possible health interventions and pulls the future close to the present to help people take charge of their health.
To succeed in the New Health Economy, organizations must innovate around the consumer. This is especially true in the areas of clinical research and the development of new drugs.
To practice precision medicine, health providers need to understand the complex impact of a person’s biology, behaviors and surroundings on the course of disease. Today, information and insights from clinical and research data are often inaccessible or lost in the “black hole” of unstructured data (e.g., patient responses, adverse events and research study notes) and disconnected systems (e.g., diagnostic images, lab reports and “-omic” databases), delaying breakthroughs in research and translation to clinical care. The Interchange from DoubleJump Health can help academic medical centers, research institutions and pharmaceutical companies securely access data to accelerate scientific discoveries and translate them into better patient care—faster.
Principal, Health Industries, PwC US
Tel: +1 (440) 258 2729
US Health Industries Advisory Leader, PwC US
Tel: +1 (860) 559 6511